[1] Owen DG,McNamee JP,Raaphorst GP,et al.Potentiation of cell killing by low-dose-rate radiation by camptothecin is related to an increase in the level of DNA double-strand breaks.Radiat Res,2002,157(2):149-157.
[2] 郑秀龙,金一尊,沈瑜.肿瘤治疗增敏药.修订本,上海:上海科学技术文献出版社,2002.152-156.
[3] Lahusen T,De Siervi A,Kunick C,et al.Alsterpaullone,a novel cyclin-dependent kinase inhibitor,induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential.Mol Carcinog,2003,36(4):183-194.
[4] Iliakis G,Wang H,Perrauh AR,et al.Mechanisms of DNA double strand break repair and chromosome aberration formation.Cytogenet Genome Res,2004,104(1-4):14-20.
[5] Wouters BG,Weppler SA,Koritzinsky M,et al.Hypoxia as a target for combined modality treatments.Eur J Cancer,2002,38(2):240-257.
[6] Pradier O,Rave-Frank M,Schmidberger H,et al.Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1),cervical squamous cell carcinoma cellscarcinoma (CaSki),and breast adenocarcinoma cells(MCF-7).J Cancer Res Clin Oncol,1999,125(1):20-27.
[7] Kotandeniya D,Ganley B,Gates KS,et al.Oxidatine DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide.Biol Med Chem Lett,2002,12(17):2325-2329.
[8] Maraveyas A,Sgouros J,Upadhyay S,et al.Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma:a phase I study.Br J Cancer,2005,92(5):815-819.
[9] 姚莉.辐射损伤与细胞周期.国外医学·放射医学核医学分册,2004,28(1):33-36.
[10] Sarkaria JN,Busby EC,Tibbetts RS,et al.Inhibition of ATM and ATR kinase activities by the radiosensitizing agent,caffeine.Cancer Res,1999,59(17):4375-4382.
[11] Tenzer A,Pruschy M.Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators.Cur Med Chem Anticancer Agents,2003,3(1):35-46.
[12] Moon C,Oh Y,Roth JA.Current status of gene therapy for lung cancer and head and neck cancer.Clin Cancer Res,2003,9(14):5055-5067.
[13] 王小兵,赵桂森.抗肿瘤放射增敏剂的研究进展.中南药学,2005,3(5):293-295.
[14] Kasid U,Dritschilo A.RAF antisense oligonuclectide as a tumor radiosensitizer.Oncogene,2003,22(37):5876-5884.
[15] Guha C,Guha U,Tribius S,et al.Antisense ATM gene therapy:a strategy to increase the radiosensitivity of human tumors.Gene Ther,2000,7(10):852-858.
[16] Herbst RS.Review of epidermal growth factor receptor biology.Int J Radiat Oncol Biol Phys,2004,59(2 Supp1):21-26.
[17] Lammering G,Hewit TH,Hawkins WT,et al.Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization.J Natl Cancer Inst,2001,93(12):921-929.
[18] Huang SM,Harari PM.Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas:inhibition of damage repair,cell cycle kinetics,and tumorangiogenesia Clin CancerRes,2000,6(6):2166-2174.